Dialectical Behavior Group Therapy is Feasible and Reduces Emotional Dysfunction in Multiple Sclerosis

Area of Science:

• Neurology
• Psychiatry
• Clinical Psychology

Background:

• Multiple sclerosis (MS) frequently co-occurs with anxiety and depression.
• Existing treatments may not fully address the psychological burden in MS patients.
• Dialectical Behavior Therapy (DBT) is an evidence-based psychotherapy for emotional dysregulation.

Purpose of the Study:

• To assess the feasibility and preliminary effectiveness of Dialectical Behavior Therapy (DBT) in patients with multiple sclerosis (MS).
• To evaluate DBT's impact on anxiety, depression, psychopathology, and quality of life in an MS population.

Main Methods:

• A pilot study involving 20 patients with MS and symptoms of anxiety or depression.
• Participants were assigned to either DBT (n=10) or standard medical care (n=10).
• Feasibility was assessed through retention and acceptability; effectiveness was measured via self-rated and clinician-rated outcomes.

Main Results:

• DBT was found to be feasible in the studied MS population, with good patient retention and acceptability.
• The DBT group demonstrated significant improvements in depressive symptoms, anxiety symptoms, general psychopathology, and quality of life.
• The standard medical care group showed no significant improvements in the measured outcomes.

Conclusions:

• This pilot study provides preliminary evidence supporting the utility of Dialectical Behavior Therapy (DBT) for managing psychological distress in multiple sclerosis (MS).
• Further research with larger sample sizes and randomized controlled trials is warranted to confirm these findings.
• DBT may be a valuable therapeutic option for individuals with MS experiencing anxiety and depression.